Mitochondrial-targeting photosensitizers have been associated with effective photodynamic responses. However, most photosensitizers absorb light between 400 and 700 nm, where light penetration through tissues is limited. Two-photon excitation is a rational approach to improve light penetration through tissues. In this report, the two-photon photophysical properties of a porphyrin–rhodamine B conjugate (TPP-Rh), previously demonstrated to target the mitochondria, were evaluated. The properties studied included: two-photon absorption (TPA) cross sections (σ₂); resonance energy transfer (RET) kinetics and dynamics; and singlet oxygen generation. The conjugation of Rh B to TPP-OH approximately doubled the σ₂ of TPP-Rh at 800 nm (40 ± 4 GM) compared with the parent porphyrin, TPP-OH (16 ± 4 GM). Furthermore, the rate of DPBF oxidation by singlet oxygen generated from TPP-Rh was twice as fast compared with that from TPP-OH (73 % versus 33% in 10 min) following two-photon excitation at 800 nm. In addition, a significantly stronger luminescence signal was detected from TPP-Rh, than from TPP-OH at 1270 nm, following two-photon excitation. This study indicates that conjugating photosensitizers to Rh B could provide greater TPA at the near-infrared range in addition to preferential mitochondrial accumulation for improved photodynamic responses.

We report the synthesis, photophysical and electrochemical properties, and in vivo fluorescence imaging of a series of new thieno–pyrrole-fused near-infrared (NIR) BODIPY agents by using a versatile intermediate as a building block. The versatile thieno–pyrrole-fused BODIPY intermediate was rationally designed to bear bromo-substituents and absorb in the mid-red region (635 nm) to act as an organic electrophile for the development of NIR multifunctional agents. The use of subsequent palladium-catalyzed and nucleophilic substitution reactions afforded highly conjugated NIR BODIPYs. The novel BODIPYs exhibit long-wavelength absorptions in the NIR region (650–840 nm). The agents produce sharp fluorescence bands, and most of them display respectable quantum yields of fluorescence (0.05–0.87) useful for biomedical imaging, as demonstrated by in vivo imaging with SBDPiR740. Interestingly, a number of agents in the series that are non-halogenated were reactive to O₂ at the triplet photo-excited state coupled with a favorable redox potential and decent fluorescence, and hence could be potential candidates for use as photosensitizers in fluorescence-guided photodynamic therapy. Furthermore, the synthetic approach allows further functionalization of the highly conjugated NIR BODIPYs to tune the excited states (PET, ICT) and to conjugate targeting moieties for enhanced biological applications.

1,2-Diaryloxyethene has recently been proposed as a linker in singlet oxygen-mediated drug release. Even though 1,2-diaryloxyethenes look very simple, their synthesis was not an easy task. Previous methods are limited to symmetric molecules, lengthy step and low yield. We report on a facile synthetic method not only for 1,2-diaryloxyethenes but also their sulfur and nitrogen analogs in yields ranging from 40 to 90% with more than 90% purity at the vinylation reaction.

Core-modified porphyrins have been explored as the second-generation photosensitizers due to their excellent photophysical properties. IY69 [(5-phenyl-10,15-bis(4-carboxylatomethoxyphenyl)-20-(2-thienyl)-21,23-dithiaporphyrin] was developed from the structure optimization guided by in vitro phototoxicity, showing potent activity (IC₅₀ = 80 nm, broadband at 5 J cm⁻², R3230AC cells). The present study demonstrates in vivo photodynamic therapy (PDT) efficacy of IY69 using a murine tumor model (colon 26 cells on BALB/c mice) and 690 nm diode laser. In vitro phototoxicity of IY69 with the diode laser was compared with that with broadband light against colon 26 cells. Attenuation of the laser light by tissue samples was determined to estimate actual power density at targets. Biodistribution in various organs 24, 48, 72 h after i.p. administration was determined. Even though IY69 phototoxicity with the diode laser was less effective than that with the broadband light, the diode laser was quite effective in vitro (IC₅₀ = 0.1 μm, 10 J cm⁻², colon 26 cells). Concentration and light dose-dependent phototoxicity was observed. A significant light attenuation of 95% and 99% was observed by skin and 3 mm muscle with skin. IY69 PDT showed significant damage on tumor and delay in tumor growth in a dose-dependent manner.